A purple and pink letter v on a white background.
December 10, 2021

How is Venus Viva™ MD different from Venus Viva™?

As a practitioner of medical aesthetics, you know that the more initials, the better and if you re familiar with our state-of-the-art Venus Viva   device, you may have noticed that it s recently been upgraded to the new, improved Venus Viva   MD. Read on to learn the difference between the two, and discover the advanced technology behind the new Venus Viva   MD  

Venus Viva™ vs. Venus Viva™ MD: Similarities  

Like Venus Viva ,   Venus Viva   MD is a fractional resurfacing system that allows customized control of ablation and coagulation for enhanced efficacy in resolving mild to severe skin damage. Using   NanoFractional   Radio Frequency (RF) with   SmartScan   technology   and d esigned with patient satisfaction in mind, it s an ideal choice for clinicians who are looking for a flexible, powerful skin resurfacing device.  Skin resurfacing continues to be one of the most popular treatments at clinics across the country for treating a variety of concerns including fine lines, wrinkles, acne scars, rosacea, stretch marks, enlarged pores, uneven texture, and other skin imperfections.  

Both devices use Venus Concept s cutting-edged applicator and radio frequency technologies.   The   DiamondPolar   applicator uses a combination of Multi-Polar Radio   Frequency (RF) and Pulsed Electro Magnetic Fields   (PEMF)   via our patented (MP) 2 technology.   The unique electrode placement of the   DiamondPolar   applicator allows for treatment around the eyes, along the   jowls, and other smaller areas   that are difficult to treat with less agile applicator models.  

Additionally, both devices are highly customizable,   allow ing   you to control both the power and pulse duration. Being able to tailor the   NanoFractional   Radio Frequency intensity to the needs of your patients results in more comfortable treatments, with better results , making the treatments safer for patients of all skin types. Therefore, the treatments have a lower incidence of post-inflammatory hyperpigmentation, or PIH, which can be a cause for concern among side effects of skin resurfacing for people with Fitzpatrick Skin Types IV-VI.  

Venus Viva™ vs. Venus Viva™ MD: Differences  

Venus Viva   MD has been upgraded to be more effective for more skin conditions by giving the choice of two pin options: the   80 pin   tip that can deliver up to 124   mJ /pin and the   160 pin   tip which can deliver up to 62   mJ /pin. The   160 pin   tip is designed to treat a wide range of conditions and is proven to improve the appearance of textural irregularities, fine lines, dyschromia, enlarged pores, and striae. For more severe dermatological concerns such as acne scarring and deep wrinkles, the   80 pin   tip is designed to deliver a greater amount of energy per pin, with a lower pin density per area, allowing for more advanced treatments.   The Venus Viva   MD applicator is equipped with state-of-the-art patented tip technology that delivers up to 700 pulses, with energy penetration of up to 800   μ m . The tips are designed for more coverage and therefore faster treatment times , and less downtime. They are better able  to address more severe skin   conditions, and  are  particularly effective in treating acne scarring.

In a study conducted by Stephen W Eubanks, MD, and James A. Solomon, MD, PhD, subjects aged 22-71   received a series of three treatments to the full face, each 4 weeks apart . The study concluded that fractional radio frequency skin resurfacing with Venus Viva   MD   produced a statistically significant improvement in acne scarring when assessed by independent blinded evaluators. No serious adverse events resulted from treatment by either applicator tip. Treatment pain was low and tolerable among subjects of all Fitzpatrick skin types. Subjects had high levels of satisfaction with the results.   ( Click here to read the study in full , and to see before-and-after photos of subject results.)  

Skin resurfacing is a robust addition to any clinic s aesthetic offerings, and you can treat more patients in less time with Venus Viva   MD, therefore maximizing both patient satisfaction and your return on investment.   Get in touch with an expert today to learn how you can grow your practice with Venus Viva   MD.  

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.